Journals / Türk Yoğun Bakım Dergisi / 2021 / Cilt: 19 - Sayı: 1

Effectiveness of Laboratory Parameters as Morbidity and Mortality Indicators in Patients with Coronavirus Disease-2019 Admitted to the Intensive Care Unit

Koronavirüs Hastalığı-2019 Tanısıyla Yoğun Bakıma Alınan Hastalarda Morbidite ve Mortalitenin Belirteçleri Olarak Laboratuvar Parametrelerinin Etkinliği

Pages
33–43
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Lung disease, bedridden status, worse renal function scores, and high C-reactive protein level was more often observed in non-survivors (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Laboratory parameters may predict the severity and mortality of coronavirus disease-2019 (COVID-19).
📊
Key Findings & Data:We investigated the relationship of laboratory findings obtained at admission and 72nd hour and mortality and morbidity of patients with pneumonia who were treated in two intensive care units.
💡
Conclusion & Impact:Lung disease, bedridden status, worse renal function scores, and high C-reactive protein level was more often observed in non-survivors (p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Laboratory parameters may predict the severity and mortality of coronavirus disease-2019 (COVID-19). We investigated the relationship of laboratory findings obtained at admission and 72nd hour and mortality and morbidity of patients with pneumonia who were treated in two intensive care units. Materials and Methods: Chart data of 75 patients (March-May 2020) were retrospectively analysed. Patient characteristics and laboratory parameters were compared according to the presence of COVID-19 and mortality. Patients with COVID-19 were compared according to mortality and gender. Results: The mean patient age was 74.7±11.3 years. COVID-19 positivity was not associated with marked differences in laboratory values. Lung disease, bedridden status, worse renal function scores, and high C-reactive protein level was more often observed in non-survivors (p

Özet

Amaç: Laboratuvar parametreleri koronavirüs hastalığı-2019’un (COVID-19) şiddet ve mortalitesini ön görebilir. Pnömoni teşhisiyle iki yoğun bakım ünitesinde tedavi edilen hastalarda ilk kabulde ve 72 saat sonra elde edilen laboratuvar bulguları ile mortalite ve morbidite arasındaki ilişkiyi inceledik. Gereç ve Yöntem: Toplam 75 hastanın kayıtlarından (Mart-Mayıs 2020) gelen bilgiler geriye dönük incelendi. Hasta özellikleri ve laboratuvar parametreleri COVID-19 ve mortalite varlığına göre karşılaştırıldı. COVID-19+ olan hastalar, mortalite ve cinsiyete göre de karşılaştırıldı. Bulgular: Ortalama yaş 74,7±11,3 yıl idi. COVID-19 pozitifliği laboratuvar değerlerinde belirgin değişikliklerle ikişkili değildi. Akciğer hastalığı, yatağa bağımlılık, kötü böbrek fonksiyon skorları ve yüksek C-reaktif protein eks hastalarda daha yaygın idi (p

🔖

Cite This Article

ERDİVANLI, B., ÖZDEMİR, A., ÖZDEMİR, A., KAZDAL, H., KAZANCIOĞLU, L., KOYUNCU, T., HIZAL, A., ERSÖZ, T., BAHÇECİ, İ., BACIK, Ş. (2022). Effectiveness of Laboratory Parameters as Morbidity and Mortality Indicators in Patients with Coronavirus Disease-2019 Admitted to the Intensive Care Unit. Türk Yoğun Bakım Dergisi, Cilt: 19 - Sayı: 1, 33–43. https://ajindex.com/articles/643393

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. World Health Organization. DirectorGeneral’s remarks at the media briefing on 2019-nCoV on 11 February 2020. Available from URL: https://www.who. int/dg/speeches/detail/who-directorgeneral-s-remarks-at-the-media-briefingon-2019-ncov-on-11-february-2020 (Accessed February 12, 2020)
  2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;323:1061-9
  3. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020;382:2372-4
  4. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708-20
  5. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934- 43
  6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62
  7. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol 2020;5:802-10
  8. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13
  9. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. Published January 28, 2020. Available from URL: https://www. who.int/publications-detail/clinicalmanagementof-severe-acute-respiratoryinfection-when-novelcoronavirus-(ncov)- infection-is-suspected Accessed January 31, 2020
  10. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–42
  11. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID19 in the New York City Area. JAMA 2020;323:2052-9
  12. Onder G, Rezza G, B